Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide
Abstract Tuberculosis is still on the top of infectious diseases list on both mobility and mortality, especially due to drug-resistance of Mycobacterium tuberculosis (M.tb). Ethionamide (ETH) is one of effective second line anti-TB drugs, a synthetic compound similar to isoniazid (INH) structurally,...
Guardado en:
Autores principales: | Hai-Nan Zhang, Zhao-Wei Xu, He-Wei Jiang, Fan-Lin Wu, Xiang He, Yin Liu, Shu-Juan Guo, Yang Li, Li-Jun Bi, Jiao-Yu Deng, Xian-En Zhang, Sheng-Ce Tao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/df874065a394449c8edcc905acde5f89 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BrlR from Pseudomonas aeruginosa is a receptor for both cyclic di-GMP and pyocyanin
por: Feng Wang, et al.
Publicado: (2018) -
Cyclic di-GMP-dependent signaling pathways in the pathogenic Firmicute Listeria monocytogenes.
por: Li-Hong Chen, et al.
Publicado: (2014) -
Nucleotide binding by the widespread high-affinity cyclic di-GMP receptor MshEN domain
por: Yu-Chuan Wang, et al.
Publicado: (2016) -
Occurrence of Cyclic di-GMP-Modulating Output Domains in Cyanobacteria: an Illuminating Perspective
por: Marco Agostoni, et al.
Publicado: (2013) -
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles
por: Joana Costa-Gouveia, et al.
Publicado: (2017)